Literature DB >> 620563

Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.

G L Pierpont, J N Cohn, J A Franciosa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 620563     DOI: 10.1378/chest.73.1.8

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  13 in total

Review 1.  Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III.

Authors:  J N Cohn
Journal:  Drugs       Date:  1994       Impact factor: 9.546

Review 2.  Use of nitrates in acute and chronic congestive heart failure.

Authors:  K Swedberg
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  Treatment of infarct related heart failure: vasodilators other than ACE inhibitors.

Authors:  J N Cohn
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

4.  Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.

Authors:  B M Massie; B Kramer; E Shen; F Haughom
Journal:  Br Heart J       Date:  1981-04

Review 5.  The treatment of heart failure. A methodological review of the literature.

Authors:  G H Guyatt
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

Review 6.  Decompensated Heart Failure and Renal Failure: What Is the Current Evidence?

Authors:  Agata Bielecka-Dabrowa; Breno Godoy; Joerg C Schefold; Michael Koziolek; Maciej Banach; Stephan von Haehling
Journal:  Curr Heart Fail Rep       Date:  2018-08

7.  Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.

Authors:  J Mehta; M Iacona; C J Pepine; C R Conti
Journal:  Br Heart J       Date:  1979-12

Review 8.  Race-based therapeutics.

Authors:  Clyde W Yancy
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

9.  Response and tolerance to oral vasodilator up-titration after intravenous vasodilator therapy in advanced decompensated heart failure.

Authors:  Frederik H Verbrugge; Matthias Dupont; Michael Finucan; Alaa Gabi; Nael Hawwa; Wilfried Mullens; David O Taylor; James B Young; Randall C Starling; W H Wilson Tang
Journal:  Eur J Heart Fail       Date:  2015-07-24       Impact factor: 15.534

Review 10.  Vasodilators. A re-evaluation of their role in heart failure.

Authors:  L W Stevenson; G Fonarow
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.